Data protection Impressum

Life sciences

Geneva-based biotech start-up FluoSphera has raised CHF 1.15 million to expand its human-relevant preclinical testing platform, supporting the shift toward more predictive and non-animal drug development models.

FluoSphera raises CHF 1.15 million to scale human-based preclinical drug testing

19 January 2026

LEM Surgical presented its Dynamis robotic platform at CES 2026, highlighting its clinical deployment in the U.S. and outlining a new development roadmap integrating NVIDIA’s physical AI technologies.

LEM Surgical showcases its Dynamis robotic system and AI roadmap at CES 2026

19 January 2026

DigeHealth has raised CHF 1.25 million to accelerate the development of a wearable device that continuously monitors gastrointestinal activity using acoustics and artificial intelligence.

DigeHealth raises CHF 1.25 million to advance continuous gastrointestinal monitoring

15 December 2025

Seven medtech start-ups have been selected for the inaugural sitem-insel Innovation Voucher program, further strengthening the canton of Bern’s growing position as a hub for translational medicine and applied life sciences innovation.

sitem-insel launches Innovation Voucher to support emerging medtech companies

10 December 2025

Geneva has inaugurated its first AI health hub at Campus Biotech to advance AI-driven care, research and neurotechnology in Western Switzerland.

Geneva inaugurates its first AI health hub at Campus Biotech

8 December 2025

Inselspital Bern has performed its 300th CAR-T cell therapy treatment, underscoring Western Switzerland’s role as a leading center for advanced immuno-oncology.

Bern’s Inselspital marks a new era in personalized cancer treatment

8 December 2025

Researchers at CHUV have validated a new stem-cell–based method to study autoimmune diseases in organs such as the brain, offering new insights into conditions like autoimmune encephalitis and multiple sclerosis.

CHUV researchers develop new method to study autoimmune diseases

2 December 2025

Artiria Medical has received CE Mark certification for its SmartGUIDE 014 guidewire, enabling commercialization across Europe and expanding clinical adoption for stroke and aneurysm interventions.

Artiria Medical obtains CE Mark for its deflectable guidewire

2 December 2025

Takeda has opened a new CHF 200 million biotechnology facility in Neuchâtel to expand aseptic filling capacity for rare disease therapies.

Takeda inaugurates CHF 200 million biotechnology facility in Neuchâtel

1 December 2025

CHUV has opened a new ambulatory radiology facility in Lausanne to centralize imaging services and modernize its diagnostic infrastructure.

CHUV opens new ambulatory radiology facility to improve patient access and diagnostic capacity

25 November 2025

1 2 3 4 5 6 7 … 48